Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. https://doi.org/10.1002/ijc.29210. Epub 2014 Oct 9.
Dødsårsaksregisteret. Tall fra Dødsårsaksregisteret for 2020. https://www.fhi.no/hn/helseregistre-og-registre/dodsarsaksregisteret/tall-fra-dodsarsaksregisteret-for-2020/. Accessed 2 Feb 2021.
Cancer Registry of Norway. Cancer in Norway 2018 - cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2019.
Kreft i Norge. https://kreftforeningen.no/om-kreft/kreft-i-norge/. Accessed 6 Oct 2020.
Marzorati C, Riva S, Pravettoni G. Who is a cancer survivor? A systematic review of published definitions. J Cancer Educ. 2017;32(2):228–37.
Nøkkeltall om kreft. https://www.kreftregisteret.no/Temasider/om-kreft/. Accessed 8 Dec 2020.
Helsedirektoratet. 'Pakkeforløp for kreft'. https://www.helsenorge.no/sykdom/kreft/pakkeforlop-for-kreft/. Accessed 25 Nov 2020.
Jacobs LA, Shulman LN. Follow-up care of cancer survivors: challenges and solutions. Lancet Oncol. 2017;18(1):e19–29.
Behandling. https://kreftforeningen.no/om-kreft/behandling/. Accessed 25 Nov 2020.
Wallace LS. A view of health care around the world. Ann Fam Med. 2013;11(1):–84.
Økonomisk støtte til pasienter. https://kreftforeningen.no/rad-og-rettigheter/okonomi/okonomisk-stotte-til-pasienter/. Accessed 25 Jan 2021.
Din rett til helsehjelp. https://www.helsenorge.no/rettigheter/rett-til-helsehjelp/. Accessed 6 Nov 2020.
Prince RM, Atenafu EG, Krzyzanowska MK. Hospitalizations during systemic therapy for metastatic lung cancer: a systematic review of real world vs clinical trial outcomes. JAMA Oncol. 2015;1(9):1333–9.
Hazell SZ, Mai N, Fu W, Hu C, Friedes C, Negron A, et al. Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact. BMC Cancer. 2020;20(1):334.
Bateni SB, Gingrich AA, Stewart SL, Meyers FJ, Bold RJ, Canter RJ. Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management. BMC Cancer. 2018;18(1):1–10.
Feliu J, Espinosa E, Basterretxea L, Paredero I, Llabrés E, Jiménez-Munárriz B, et al. Prediction of unplanned hospitalizations in older patients treated with chemotherapy. Cancers (Basel). 2021;13(6):1437.
Fidjeland HL, Vistad I, Gjelstad S, Brekke M. Exploring why patients with cancer consult GPs: a 1-year data extraction. BJGP Open. 2019;3(4):bjgpopen19X101663.
Institute of Medicine and National Research Council. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington: The National Academies Press; 2006. https://doi.org/10.17226/11468.
Nipp RD, El-Jawahri A, Moran SM, D'Arpino SM, Johnson PC, Lage DE, et al. The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer. Cancer. 2017;123(23):4720–7.
Earle CC, Neville BA, Fletcher R. Mental health service utilization among long-term cancer survivors. J Cancer Surviv. 2007;1(2):156–60.
Montgomery M, Huang S, Cox CL, Leisenring WM, Oeffinger KC, Hudson MM, et al. Physical therapy and chiropractic use among childhood cancer survivors with chronic disease: impact on health-related quality of life. J Cancer Surviv. 2011;5(1):73–81.
Fagervoll JS, Sund AM, Zeltzer LK, Ådnanes M, Jensberg H, Eikemo TA, et al. Health-related quality of life and psychological distress in young adult survivors of childhood cancer and their association with treatment, education, and demographic factors; 2017.
Rodriguez JL, Hawkins NA, Berkowitz Z, Li C. Factors associated with health-related quality of life among colorectal cancer survivors. Am J Prev Med. 2015;49(6):S518–27.
Weaver KE, Forsythe LP, Reeve BB, Alfano CM, Rodriguez JL, Sabatino SA, et al. Mental and physical health–related quality of life among US cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Prev Biomark. 2012;21(11):2108–17.
Salloum RG, Hornbrook MC, Fishman PA, Ritzwoller DP, O'Keeffe Rossetti MC, Elston Lafata J. Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012;118(22):5644–51.
Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol. 2007;25(9):1074–81.
Elston Lafata J, Simpkins J, Schultz L, Chase GA, Johnson CC, Yood MU, et al. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005;43(6):592–9.
Fremtidens kreftkostnader - Utvikling i kreftkostnader over tid — Årsaker og utfordringer. Edited by Oslo Economics. 2019. https://osloeconomics.no/rapport-om-fremtidens-kreftkostnader/.
Legevakt. Helsedirektoratet. https://www.helsenorge.no/hjelpetilbud-i-kommunene/legevakt/. Accessed 3 Nov 2021.
Sandvik H, Hunskaar S. Frequent attenders at primary care out-of-hours services: a registry-based observational study in Norway. BMC Health Serv Res. 2018;18(1):1–10.
Buckner C, Lafrenie R, Dénommée J, Caswell J, Want D. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol. 2018;25(4):e275.
Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187–203.
Wode K, Henriksson R, Sharp L, Stoltenberg A, Nordberg JH. Cancer patients’ use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med. 2019;19(1):62.
WHO. Traditional, Complementary and Integrative Medicine. https://www.who.int/health-topics/traditional-complementary-and-integrative-medicine#tab=tab_1. Accessed 2 Nov 2020.
Act No. 64 of 27 June 2003 relating to the alternative treatment of disease, illness, etc. https://app.uio.no/ub/ujur/oversatte-lover/data/lov-20030627-064-eng.pdf. Accessed 3 Nov 2020.
Hanssen B, Grimsgaard S, Launsø L, Fønnebø V, Falkenberg T, Rasmussen NK. Use of complementary and alternative medicine in the Scandinavian countries. Scand J Prim Health Care. 2005;23(1):57–62.
Yim J, Shaw J, Viney R, Arora S, Ezendam N, Pearce A. Investigating the association between self-reported comorbid anxiety and depression and health service use in cancer survivors. Pharmacoeconomics. 2021;39(6):681–90.
Maddams J, Utley M, Møller H. Levels of acute health service use among cancer survivors in the United Kingdom. Eur J Cancer. 2011;47(14):2211–20.
Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17(1):38.
Jeppesen EJL. Komplementær og alternativ behandling for pasienter med kreft. In: Rapport fra Kunnskapssenteret nr 12-2011. Oslo: Nasjonalt kunnskapssenter for helsetjenesten; 2011.
Kristoffersen AE, Norheim AJ, Fønnebø VM. Complementary and alternative medicine use among Norwegian cancer survivors: gender-specific prevalence and associations for use. Evid Based Complement Alternat Med. 2013;2013:318781.
Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655–63.
Bennett M, Lengacher C. Use of complementary therapies in a rural cancer population. In: Oncology Nursing Forum-Oncology Nursing Society: 1999. Pittsburgh: Oncology Nursing Society; 1999. p. 1287–94.
Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505–14.
Bernstein BJ, Grasso T. Prevalence of complementary and alternative medicine use in cancer patients. Oncology (Williston Park, NY). 2001;15(10):1267–72 discussion 1272.
Salomonsen LJ, Skovgaard L, la Cour S, Nyborg L, Launso L, Fonnebo V. Use of complementary and alternative medicine at Norwegian and Danish hospitals. BMC Complement Altern Med. 2011;11:4.
Jacobsen R, Fønnebø V, Foss N, Kristoffersen AE. Use of complementary and alternative medicine within Norwegian hospitals. BMC Complement Altern Med. 2015;15(1):275.
Vardesenteret. https://kreftforeningen.no/vardesenteret/. Accessed 8 Dec 2020.
Tilbud og aktiviteter. https://kreftforeningen.no/vardesenteret/tilbud/. Accessed 8 Dec 2020.
Kristoffersen AE, Norheim AJ, Fønnebø VM. Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD. BMC Complement Altern Med. 2012;12(1):1–8.
Reid R, Steel A, Wardle J, Trubody A, Adams J. Complementary medicine use by the Australian population: a critical mixed studies systematic review of utilisation, perceptions and factors associated with use. BMC Complement Altern Med. 2016;16(1):1–23.
Kersnik J. Predictive characteristics of users of alternative medicine. Schweiz Med Wochenschr. 2000;130(11):390–4.
Fylkesmannen i Troms. Folketallsutviklingen i Troms i 2016. https://www.statsforvalteren.no/siteassets/utgatt/fm-troms/bilder-fmtr/jusa/folketallsutviklingen-i-troms-2016-rettet.pdf. Accessed 5 Feb 2021.
The seventh survey of the Tromsø Study. https://uit.no/research/tromsostudy/project?pid=708909. Accessed 5 Feb 2021.
Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso study. Int J Epidemiol. 2012;41(4):961–7.
Norwegian national identity number. The Norwegian Tax Administration. https://www.skatteetaten.no/en/person/national-registry/birth-and-name-selection/children-born-in-norway/national-id-number/. Accessed 2 Feb 2020.
Devlin N, Parkin D, Janssen MF. An introduction to EQ-5D instruments and their applications; 2020. p. 1–22.
Quandt SA, Verhoef MJ, Arcury TA, Lewith GT, Steinsbekk A, Kristoffersen AE, et al. Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med. 2009;15(4):331–9.
Xu F, Johnston JM. Self-rated health and health service utilization: a systematic review. Int J Epidemiol. 2015;44(suppl_1):i180.
Rana RH, Alam K, Gow J, Ralph N. Predictors of health care use in Australian cancer patients. Cancer Manag Res. 2019;11:6941.
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021. https://doi.org/10.1002/ijc.33588.
DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15.
Rietman JS, Dijkstra PU, Debreczeni R, Geertzen JH, Robinson DP, De Vries J. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2004;26(2):78–84.
Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, Admiraal JM, den Boer MD, et al. Health care use and remaining needs for support among women with breast cancer in the first 15 months after diagnosis: the role of the GP. Fam Pract. 2019;37(1):103–9.
Low CA, Beckjord E, Bovbjerg DH, Dew MA, Posluszny DM, Schmidt JE, et al. Correlates of positive health behaviors in cancer survivors: results from the 2010 LIVESTRONG survey. J Psychosoc Oncol. 2014;32(6):678–95.
Steinsbekk A, Adams J, Sibbritt D, Johnsen R. Complementary and alternative medicine practitioner consultations among those who have or have had cancer in a Norwegian total population (Nord-Trøndelag Health Study): prevalence, socio-demographics and health perceptions. Eur J Cancer Care. 2010;19(3):346–51. https://doi.org/10.1111/j.1365-2354.2008.01049.x.
Mausbach BT, Irwin SA. Depression and healthcare service utilization in patients with cancer. Psychooncology. 2017;26(8):1133–9.
World Health Organization. WHO guidelines on basic training and safety in chiropractic. World Health Organization; 2005. https://apps.who.int/iris/handle/10665/43352.
Gatterman MI. Foundations of chiropractic: subluxation. St. Louis: Elsevier Health Sciences; 2005.
Hughes C, Quinn F, Baxter G. Complementary and alternative medicine: perception and use by physiotherapists in the management of low back pain. Complement Ther Med. 2011;19(3):149–54.
Busato A, Dönges A, Herren S, Widmer M, Marian F. Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland—an observational study. Fam Pract. 2005;23(1):116–24.
Al-Windi A. Determinants of complementary alternative medicine (CAM) use. Complement Ther Med. 2004;12(2-3):99–111.
Li JZ, Quinn JV, McCulloch CE, Jacobs BP, Chan PV. Patterns of complementary and alternative medicine use in ED patients and its association with health care utilization. Am J Emerg Med. 2004;22(3):187–91.
Strömbom Y, Magnusson P, Karlsson J, Fredrikson M. Health-related quality of life among frequent attenders in Swedish primary care: a cross-sectional observational study. BMJ Open. 2019;9(7):e026855.
Kristoffersen AE, Fønnebø V, Norheim AJ. Do cancer patients with a poor prognosis use complementary and alternative medicine more often than others? J Altern Complement Med. 2009;15(1):35–40.
Reijneveld SA, Stronks K. The validity of self-reported use of health care across socioeconomic strata: a comparison of survey and registration data. Int J Epidemiol. 2001;30(6):1407–14.
Engstad T, Bonaa KH, Viitanen M. Validity of self-reported stroke: the Tromso study. Stroke. 2000;31(7):1602–7.
Lundblad MW, Jacobsen BK. The reproducibility of self-reported age at menarche: the Tromsø study. BMC Womens Health. 2017;17(1):62.
Johansson BB, Holmberg L, Berglund IG, Sjödén P, Glimelius BL. Determinants of cancer patients’ utilization of hospital care within two years after diagnosis. Acta Oncol. 2004;43(6):536–44.
Gerich J, Moosbrugger R, Heigl C. Health literacy and age-related health-care utilisation: a multi-dimensional approach. Ageing Soc. 2020:1–22. https://doi.org/10.1017/S0144686X20001609.